BioCryst Reports Second Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to BioCryst Reports Second Quarter 2015 Financial Results

BioCryst Pharma (BCRX) Posts Surprise Q2 Profit

August 7, 2015 6:52 AM EDT

BioCryst Pharma (NASDAQ: BCRX) reported Q2 EPS of $0.07, $0.29 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $25.8 million versus the consensus estimate of $7.1 million.

Cash, cash equivalents and investments increased to $132.0 million at June 30, 2015, compared to $114.0 million at December 31, 2014. This increase resulted primarily from the RAPIVAB upfront licensing... More